We recognize that a subset of the genes we identified in our analysis of this dataset are opposite of what has been reported in prior work, specifically MMP9 and ESR1, as being upregulated in Letrozole-resistant breast cancer tumors, which agrees with our findings [128]. Here, ESR1 is linked to breast carcinoma.